LAKE FOREST, Calif., June 27, 2022 /PRNewswire/ — BIOLASEInc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its partnership with HOME project, an organization that provides dental services to patients from their first birthday through adulthood. Project HOME Health Services is a Federally Registered Health Center (FQHC) and supports health care services, regardless of a person’s ability to pay for services, in Philadelphia.

Project HOME’s mission is to empower adults, children and families to break the cycle of homelessness and poverty, alleviate the underlying causes of poverty and enable individuals to achieve their full potential as individuals and as members of society at large. Project HOME strives to create a safe and respectful environment to support people struggling with self-esteem, recovery, confidence, as well as mental and physical health.

Project HOME’s dental services are part of a patient-centered integrated health care services model, where many dental patients are also primary care patients. This allows medical issues that may be impacting oral health to be quickly identified and treatment initiated to improve overall patient well-being.

During a ride-accompanied with the BIOLASE team in philadelphia creamCEO of BIOLASE, John Beaver, was invited to visit Project HOME to see how the company could help people in need. “At BIOLASE, our goal is to develop dental laser technology that provides a higher level of patient care and improves patients’ oral health,” Beaver said. “Supporting the HOME project in its mission gives BIOLASE the opportunity to make a meaningful contribution to the overall health of the community.”

“It is a great honor that BIOLASE is partnering with Project HOME to help provide dental care to our members. With the donation of an iPlus Waterlase laser system and the training program offered to our doctors and staff at the dental facility of Project HOME in philadelphia creamthe modern technology offered by BIOLASE will help provide a new standard of care for HOME project members,” commented Dr. Janine Burkhardt, dental director of the HOME project. “Enhancing the already excellent care each member receives, while helping physicians perform more treatments in a single visit, will have a significant impact on our ability to achieve our mission and improve oral health outcomes for our members.”

About the HOME project

Since 1989, Project HOME has helped thousands of people break the cycle of homelessness and poverty by providing a continuum of care that includes street outreach, supportive housing, and comprehensive services focused on health care, education and employment through adult and youth education and enrichment. programs. To learn more, visit


BIOLASE is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. BIOLASE products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE’s proprietary laser products incorporate approximately 301 patented and 32 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE’s innovative products offer advanced technology at competitive prices to deliver superior results for dentists and patients. BIOLASE’s main products are revolutionary dental laser systems that perform a wide range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 43,300 laser systems to date in over 80 countries worldwide. The laser products under development address BIOLASE’s core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™ and laser dentistry, find BIOLASE online at www.biolase.comFacebook at at at LinkedIn on

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Caution Regarding Forward-Looking Statements

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties, including statements regarding the planned deployment of new market sales strategies, the Company’s efforts to achieve its goal of becoming EBITDA positive. Forward-looking statements can be identified by the use of words such as “anticipate”, “expect”, “intend”, “plan”, “believe”, “seek”, “estimate”, ” may”, “will”, “should” and variations of these words or similar expressions. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE’s current expectations and speak only as of the date of this release. Actual results may differ materially from BIOLASE’s current expectations based on a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including, but not limited to, pricing pressures and new product launches, uncertainty as to customer acceptance of new product offerings and market changes, the risks associated with managing the growth of the business, and the other risks and uncertainties that are described, from time to time, in the section “Risk Factors” in BIOLASE’s annual reports filed on Form 10-K with the Securities and Exchange Commission. Except as required by law, BIOLASE assumes no responsibility to revise or update forward-looking statements.

For more information, please contact:
Michel Polyviou / Todd Kehrli
(732) 933-2754
[email protected] / [email protected]